Profil
Said Saim formerly worked at Collegium Pharmaceutical, Inc., as Senior Director-Pharmaceutical Development from 2008 to 2013, Boehringer Ingelheim Pharmaceuticals, Inc., as Principal Scientist, Higuchi Bioscience Center, as Assistant Research Professor, and EyePoint Pharmaceuticals, Inc., as Chief Technology Officer & Senior VP from 2019 to 2024.
Dr. Saim received his graduate degree and doctorate degree from the University of Kansas.
Tidigare kända positioner av Said Saim
| Företag | Position | Slut |
|---|---|---|
| EYEPOINT, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-12-01 |
Higuchi Bioscience Center | Företagsledare/Principal | - |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Företagsledare/Principal | - |
| COLLEGIUM PHARMACEUTICAL, INC. | Företagsledare/Principal | - |
Said Saims utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Higuchi Bioscience Center |
















